Almirall, S.A.
OTC: LBTSF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Carlos Gallardo Piqué
- Employees
- 2,026
- Headquarters
- Barcelona, Spain
- IPO year
- 2012
- Market cap
- $3.3B
- Website
- https://www.almirall.com
Loading LBTSF…
Loading profile data…Frequently asked questions about LBTSF
What does Almirall, S.A. (LBTSF) do?
Almirall, S.A. is a biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of dermatology-focused pharmaceuticals. Its operations span Europe, the United States, and various international markets. The company provides treatments targeting a wide array of skin conditions, including actinic kerato...
Where does LBTSF trade?
Almirall, S.A. (LBTSF) trades on the Other OTC.
What sector is LBTSF in?
Almirall, S.A. (LBTSF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Almirall, S.A.?
Carlos Gallardo Piqué is the chief executive officer of Almirall, S.A. (LBTSF).
Where is Almirall, S.A. headquartered?
Almirall, S.A. is headquartered in Spain.
Does LBTSF pay a dividend?
Yes — Almirall, S.A. (LBTSF) paid a trailing twelve-month dividend of USD 0.18 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did LBTSF go public?
Almirall, S.A. (LBTSF) completed its initial public offering in 2012.